A leading provider of diagnostic services, Metropolis Healthcare Ltd., announced the establishment of its Metropolis Innovation Cell, which will concentrate on Molecular Genomics, Superspeciality Pathology, and Companion Diagnostics. This announcement is in keeping with the company’s commitment to ensuring that everyone has access to high-quality, cutting-edge, and affordable diagnostic testing. Metropolis is introducing a number of specialized diagnostics for pregnancy, cancer, infectious diseases, and transplant management under Innovation Cell.

The main goal is to increase its capacity in various regions and continually search for new ways to provide patients with “cheap” testing across the nation, including in tier 2 and tier 3 cities. Metropolis has served more than 600 customers in West Bengal through a variety of patient collection centers and pick-up places. Patients will be able to access the new specialized tests at any of the centers in Kolkata and throughout West Bengal, and the staff will make sure that accurate and thorough findings are delivered with the shortest turnaround times possible.

Finding the disease’s underlying cause is a victory. The diagnostic industry steps in at this point. At Metropolis, staff members not only pinpoint the underlying issue but also look at patterns and recommend potential solutions. To communicate and exchange knowledge on diagnoses and tests, they regularly interact with clinicians, hospitals, and healthcare industry groups through a variety of CMEs, webinars, and round table meetings. Automation and digitization enable smart reports to physicians for more efficient and improved clinical decision-making.